Nephrology: 2. Evaluation of asymptomatic hematuria and proteinuria in adult primary care

CMAJ. Canadian Medical Association Journal

Volumn 166, Issue 3, 2002, Pages 348-353

  House, Andrew A ^a   Cattran, Daniel C ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

ALCOHOL CONSUMPTION; ANAMNESIS; BLOOD PRESSURE; CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG USE; EMPLOYMENT; FATIGUE; GLOMERULOPATHY; HEALTH STATUS; HEMATURIA; HUMAN; HYPERTENSION; INFECTION; INFLAMMATION; INSURANCE; KIDNEY COLIC; KIDNEY DISEASE; MALIGNANT NEOPLASTIC DISEASE; MARRIAGE; MENSTRUATION; NEPHROLOGY; OCCUPATIONAL EXPOSURE; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRIMARY MEDICAL CARE; PROTEINURIA; REVIEW; SYSTEMIC DISEASE; URINARY TRACT INFECTION;

EID: 0036167412     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Asymptomatic microhematuria and urologic disease. A population-based study
2. A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults
3. Significance of microhaematuria in young adults
4. Microscopic haematuria
5. Dipstick haematuria and bladder cancer in men over 60: Results of a community study
6. Urinalysis. When - And when not - To order
7. Differentiation of hematuria using a uniquely shaped red cell
8. The evaluation of adult hematuria: A clinical update
9. Urinalysis
10. Asymptomatic urinary abnormalities. Hematuria and proteinuria
11. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis
12. Urinary bladder carcinogenesis
13. Urothelial lesions in Chinese-herb nephropathy
14. Elevated levels of serum creatinine: Recommendations for management and referral
15. Strategies for asymptomatic microscopic hematuria: A prospective study of 1,034 patients
16. NMP22: A sensitive, cost-effective test in patients at risk for bladder cancer
17. Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer
18. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice
19. Isolated hematuria in adults: IgA nephropathy is a predominant cause of hematuria compared with thin glomerular basement membrane nephropathy
20. Clinical audit of the use of renal biopsy in the management of isolated microscopic hematuria
21. Hematuria due to hypercalciuria and hyperuricosuria in adult patients
22. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria
23. Isolated proteinuria in asymptomatic patients
24. Proteinuria
25. Fixed and reproducible orthostatic proteinuria: Results of a 20-year follow-up study
26. Pathophysiology of progressive nephropathies
27. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
28. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
29. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
30. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
31. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes